Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ocugen, Inc.OCGN · Entity 5550 | CAO/SVP, Finance | January 03, 2023 | February 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ocugen, Inc.
Report date January 03, 2023 · Filed February 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 161,478 |
Reported balance
After 2023-01-03 transaction · row 1
1 source rowRow 1 · 2023-01-03 · Tax withholding · Disposed 1,913 · Balance 161,478 F1: This Form 4 is being filed late due to an administrative error. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed late due to an administrative error.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2023 Filed Jan 5, 2023 21:07 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantOption (Right to Buy) · Derivative | 147,638 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001062993-23-000488 · form4.xml · derivative · entry 2 Crespo Jessica · CIK 0001918616 · CAO/SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,638 Underlying: Common Stock · 147,638 shares Expires 2033-01-03 F2 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 3, 2024, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:07 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantCommon Stock | 122,951 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000488 · form4.xml · nonDerivative · entry 1 Crespo Jessica · CIK 0001918616 · CAO/SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,391 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Ocugen Inc.'s (the "Company's") common stock. The RSUs vest annually in three equal installments commencing on January 3, 2024, subject to continued service with the Company on the applicable vesting dates. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
| January 03, 2023 Filed Feb 17, 2023 22:12 UTC | Ocugen, Inc. OCGN · Entity 5550 | Tax withholdingCommon Stock | 1,913 | $1.25 | $2,391.25 |
DisclosureSEC source: 0001062993-23-004082 · form4.xml · nonDerivative · entry 1 Crespo Jessica · CIK 0001918616 · CAO/SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,478 F1 · date: This Form 4 is being filed late due to an administrative error. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 22:45 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantOption (Right to Buy) · Derivative | 84,192 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001062993-22-008356 · form4.xml · derivative · entry 2 Crespo Jessica · CIK 0001918616 · CAO/SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,192 Underlying: Common Stock · 84,192 shares Expires 2032-03-18 F2 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on March 18, 2023, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 22:45 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantCommon Stock | 22,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-008356 · form4.xml · nonDerivative · entry 1 Crespo Jessica · CIK 0001918616 · CAO/SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,440 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Ocugen, Inc's (the "Company's") common stock. The restricted stock units vest annually in three equal installments commencing on March 18, 2023, subject to continued employment with the Company on the applicable vesting dates. The restricted stock units will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.